The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 29, 2016
Filed:
Oct. 25, 2013
Applicant:
Allergan, Inc., Irvine, CA (US);
Inventor:
John S. Garrett, Fort Collins, CO (US);
Assignee:
Allergan, Inc., Irvine, CA (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/18 (2006.01); A61Q 17/04 (2006.01); A61K 31/415 (2006.01); A61K 31/135 (2006.01); A61K 31/10 (2006.01); A61K 31/145 (2006.01); A61K 8/46 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 47/32 (2006.01); A61Q 19/00 (2006.01); A61K 31/4164 (2006.01);
U.S. Cl.
CPC ...
A61K 31/145 (2013.01); A61K 8/46 (2013.01); A61K 9/0048 (2013.01); A61K 9/06 (2013.01); A61K 31/4164 (2013.01); A61K 47/32 (2013.01); A61Q 19/00 (2013.01);
Abstract
The methods described herein provide treatment of rosacea using topical formulations of dapsone. The methods also provide treatment of rosacea with topical dapsone in combination with other active agents, including metronidazole. The methods avoid negative hematologic side effects, including hemolysis and hemolytic anemia, that are associated with oral administration of dapsone.